Atlas Trials

Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19

Clinical trial NCT04413864 · UNKNOWN

Trial details

NCT number
NCT04413864
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
SARS-CoV 2
Start date
2020-04-24
Primary completion
2022-10-24
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.